Cryosurgery or Cryotherapy is a minimally invasive treatment that subjects the use of extremely cold temperatures to freeze and destroy diseased tissues, largely used in the treatment of cancer. To freeze the diseased cells, (inside or outside the body) liquid nitrogen, argon gas, carbon dioxide gas & dimethyl ether- propane are applied. Some image guiding techniques such as ultrasound, computed tomography (CT) or magnetic resonance (MR) are also used in the practice of cryotherapy. Being a minimally intrusive procedure, cryosurgery is largely preferred over open surgeries. Moreover, there is a minimal side effect to this practice as its application is localized and restricted to the abnormal tissues only. The immense demand for such procedures are increasing and boosting the cryosurgery market. Skilled healthcare professionals, available disposable incomes and favorable reimbursement policies are the key factors responsible for market growth. Every market has its pros & cons, as does the cryosurgery market. Besides various merits, some common side effects like erythema, pain, hypopigmentation and lower effectiveness of treatment are some common limitations for the market growth. However, advancements in technology should help to sustain and overcome these challenges, eventually, boosting the market growth.
The Asia Pacific cryosurgery market is segmented on the basis of application, technique and geography. The application segment is further categorized into Skin tumors, Actinic keratosis, Nodules, Skin tags, Unsightly freckles, Retinoblastomas and Cancers (prostate, liver, and cervical). WHO, states that cancer mortality in the developing countries is expected to reach 6.7 million by 2015. This statistics put a high demand forward for the cure of cancer across the globe. This rising rifeness will ultimately boost the market growth in future. Based on technique, the Asia Pacific cryosurgery market is segmented into Spray technique, Dipstick applicator method, Cryoprobe, Thermo-couple device and Forceps technique. The Asia Pacific cryosurgery market is segmented into China, Japan, India, Australia and others. The expected increase in cancer mortality rates in countries such as India, China, Japan, and Brazil, highlight a lucrative market scenario. Increasing per capita income and growing awareness of available medical services, is expected to drive the cryotherapy market in these developing economies.
KEY TAKE AWAYS
In-depth coverage of the Asia Pacific cryosurgery market including drivers, restraints and opportunities should help professionals to better understand market behavior
The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2013-2020 in terms of value
A detailed study of the strategies of key leaders, partnerships and acquisitions in the Asia Pacific cryosurgery market would be informative for professionals in the corporate sector
Pin-point analysis of geographic segments helps to identify opportunities for growth within the Asia Pacific cryosurgery market
A market attractiveness analysis has been included for various product segments, testing procedures, end users and geographic regions along with a detailed analysis of factors responsible for the rapid growth of market segments
Ease of doing business analysis should help in making strategic business decisions
CRYOSURGERY MARKET KEY SEGMENTS
The Asia Pacific cryosurgery market is segmented into three major categories: application, end user and geography.
Cancer -prostate, liver, and cervical
Dipstick applicator method
Asia Pacific Cryosurgery Market Report Highlights
Key Market Players
Mectronic Medicale,, Brymill Cryogenic Systems,, Galil Medical, Inc., S.r.l, Medtronic,, CORTEX TECHNOLOGY,, Erbe Elektromedizin, GmbH,, CryoConcepts LP,, Metrum Cryoflex,, CooperSurgical, Inc.,, Cryoalfa,